Are Suicide-Specific Interventions Required to Reduce Suicidal Ideation? An Empirical Examination in a Clinical Sample of Eating Disorder Participants.
Morgan Robison, Mina Velimirovic, Tyler Rice, Alan Duffy, Megan Riddle, Jamie Manwaring, Renee D Rienecke, Susan McClanahan, Dan V Blalock, Daniel Le Grange, Philip S Mehler, Thomas E Joiner
{"title":"Are Suicide-Specific Interventions Required to Reduce Suicidal Ideation? An Empirical Examination in a Clinical Sample of Eating Disorder Participants.","authors":"Morgan Robison, Mina Velimirovic, Tyler Rice, Alan Duffy, Megan Riddle, Jamie Manwaring, Renee D Rienecke, Susan McClanahan, Dan V Blalock, Daniel Le Grange, Philip S Mehler, Thomas E Joiner","doi":"10.1177/21677026241274746","DOIUrl":null,"url":null,"abstract":"<p><p>This research examined whether non-suicide-specific treatments effectively reduced suicidal ideation (SI) among a clinical sample of eating disorder (ED) patients (<i>N</i>=3,447 of whom 50.9% presented with SI). All participants met criteria for a current <i>DSM-5</i> ED and were administered a combination of evidence-based treatments in inpatient, residential, partial hospitalization, and intensive outpatient ED treatment facilities. Mediation analyses tested whether SI at discharge decreased specifically through standardized residual change scores in ED symptoms. Both SI and ED symptoms decreased over the course of treatment without clinically meaningful differences by ED diagnosis. ED symptom improvement partially mediated the relationship between SI at admission and discharge, suggesting that treating ED symptoms with evidence-based treatments can be an effective way to reduce SI, at least partially, for many patients. These findings demonstrate the importance of facilitating evidence-based treatment referrals for specific disorders as a component of broad-based suicide outreach and prevention strategies.</p>","PeriodicalId":54234,"journal":{"name":"Clinical Psychological Science","volume":"13 3","pages":"447-461"},"PeriodicalIF":4.1000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12356102/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Psychological Science","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/21677026241274746","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/10/6 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0
Abstract
This research examined whether non-suicide-specific treatments effectively reduced suicidal ideation (SI) among a clinical sample of eating disorder (ED) patients (N=3,447 of whom 50.9% presented with SI). All participants met criteria for a current DSM-5 ED and were administered a combination of evidence-based treatments in inpatient, residential, partial hospitalization, and intensive outpatient ED treatment facilities. Mediation analyses tested whether SI at discharge decreased specifically through standardized residual change scores in ED symptoms. Both SI and ED symptoms decreased over the course of treatment without clinically meaningful differences by ED diagnosis. ED symptom improvement partially mediated the relationship between SI at admission and discharge, suggesting that treating ED symptoms with evidence-based treatments can be an effective way to reduce SI, at least partially, for many patients. These findings demonstrate the importance of facilitating evidence-based treatment referrals for specific disorders as a component of broad-based suicide outreach and prevention strategies.
期刊介绍:
The Association for Psychological Science’s journal, Clinical Psychological Science, emerges from this confluence to provide readers with the best, most innovative research in clinical psychological science, giving researchers of all stripes a home for their work and a place in which to communicate with a broad audience of both clinical and other scientists.